Best Ophthalmology Journals (2026): Ranked by Impact and Accessibility

This journal has the highest IF in ophthalmology, but it's essentially invitation-only for thorough review articles. You don't submit original research here. If you're an established expert and receive an invitation, it's a significant career milestone. The articles are exhaustive, often 30+ pages, and become definitive references in their areas.

The American Academy of Ophthalmology's flagship journal is the most competitive venue for original clinical research in the field. It publishes large RCTs, major epidemiological studies, and high-impact clinical findings across all subspecialties. The editorial process is fast and professional. If your study has the potential to change clinical practice in any area of ophthalmology, this is where it should go first. The journal also publishes excellent editorials and research letters.

Part of the JAMA network, this journal benefits from the brand's massive reach into general medicine. It prioritizes evidence-based clinical research, systematic reviews, and health services research. Publications here get noticed by non-ophthalmologists, which matters for work with public health implications. The review process is rigorous and expects impeccable methodology.

AJO is one of the oldest continuously published ophthalmology journals and remains a strong choice for clinical and surgical research. It's less selective than Ophthalmology or JAMA Ophthalmology but still competitive. AJO is particularly good for surgical outcome studies, case series with large numbers, and clinical innovations. The readership is primarily practicing ophthalmologists.

BJO serves as the primary international clinical ophthalmology journal outside the US market. It publishes clinical research, reviews, and educational content with a global perspective. European and Asian authors sometimes find a warmer reception here compared to the US-centric journals. The quality of review is consistent, and the journal has a loyal readership.

If your work is specifically about retinal diseases, Retina is the leading subspecialty journal. It publishes clinical research, surgical techniques, and imaging studies related to retinal conditions. The focused readership means your work reaches the exact specialists who need to see it. Sending retina-specific research to a generalist journal often means less expert review.

For cornea, tear film, dry eye, and ocular surface disease research, this journal has become the definitive venue. Its IF has climbed steadily as dry eye research has expanded. If your work involves the anterior segment or ocular surface biology, consider Ocular Surface before generalist titles.

Investigative Ophthalmology & Visual Science is ARVO's flagship and the top journal for basic and translational vision research. It doesn't publish clinical trials. Instead, it's the home for laboratory science, animal models, imaging technology development, and visual neuroscience. If your paper involves wet lab work or computational modeling related to vision, IOVS is the appropriate target.

AAO launched this OA companion to the main Ophthalmology journal, and it's quickly become a credible option. It publishes original research that's scientifically sound but may not reach the novelty bar for the parent journal. The connection to AAO provides visibility, and the OA model ensures broad access.

ARVO's OA journal bridges bench science and clinical application. It's particularly good for imaging studies, technology development, and translational work. The APC is lower than most competitors, making it accessible for researchers with limited funding. The review process is constructive.

For basic science that doesn't reach IOVS, Experimental Eye Research is a natural alternative. It publishes cell biology, molecular biology, and pharmacology studies related to the eye. The journal has a long history and stable readership in the basic science community.

A broad OA journal that accepts well-designed studies across all of ophthalmology. The acceptance rate is higher and the bar is scientific soundness rather than perceived impact. A pragmatic option for observational studies, small trials, and research from resource-limited settings.

If your paper is a large RCT with practice-changing results, Ophthalmology should be your first submission. JAMA Ophthalmology is a close second.

If your paper is clinical but subspecialty-specific, consider Retina or Ocular Surface before generalist journals. Expert reviewers at subspecialty journals will evaluate your work more fairly.

If your paper is basic science or translational, IOVS is the standard. For work that doesn't reach IOVS, try Experimental Eye Research or TVST.

If your paper needs open access, Ophthalmology Science and TVST are the best society-backed options. BMJ Open Ophthalmology offers a broader scope.

If your paper is a surgical outcome study or technique description, AJO has the strongest tradition of publishing surgical research.